The Genetic Risk of Kidney Disease in Type 2 Diabetes

被引:33
|
作者
Pezzolesi, Marcus G. [1 ,2 ]
Krolewski, Andrzej S. [1 ,2 ]
机构
[1] Joslin Diabet Ctr, Sect Genet & Epidemiol, Div Res, Boston, MA 02215 USA
[2] Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA
基金
美国国家卫生研究院;
关键词
Type; 2; diabetes; Diabetic nephropathy; Kidney disease; Genetic risk; STAGE RENAL-DISEASE; URINARY ALBUMIN EXCRETION; GLOMERULAR-FILTRATION-RATE; GENOME-WIDE SCAN; FAMILIAL PREDISPOSITION; SUSCEPTIBILITY GENES; AFRICAN-AMERICANS; LEUCINE REPEAT; PIMA-INDIANS; LINKAGE SCAN;
D O I
10.1016/j.mcna.2012.10.005
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
In this review, the authors discuss the major approaches being used to identify diabetic nephropathy (DN) susceptibility genes in type 2 diabetes (12D) and highlight the salient findings from studies whereby these approaches have been implemented. The recent advent of next-generation sequencing technology is beginning to impact DN gene mapping strategies. As the field moves forward, family based approaches should greatly facilitate efforts to identify variants in genes that have a major effect on the risk of DN in T2D. To be successful, the ascertainment and comprehensive study of families with multiple affected members is critical.
引用
收藏
页码:91 / +
页数:18
相关论文
共 50 条
  • [1] Type 2 diabetes genetic risk score and morbidity and mortality associated with diabetic kidney disease
    Galuska, D.
    Janakova, M.
    Bednarikova, B.
    Chalasova, K.
    Pacal, L.
    Kankova, K.
    [J]. DIABETOLOGIA, 2019, 62 : S491 - S491
  • [2] Kidney Disease and Increased Mortality Risk in Type 2 Diabetes
    Afkarian, Maryam
    Sachs, Michael C.
    Kestenbaum, Bryan
    Hirsch, Irl B.
    Tuttle, Katherine R.
    Hinnmelfarb, Jonathan
    de Boer, Ian H.
    [J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2013, 24 (02): : 302 - 308
  • [3] Genetic Risk for coronary Heart Disease with Type 2 Diabetes
    Pavlicek, V.
    [J]. DIABETOLOGE, 2013, 9 (07): : 565 - 566
  • [5] Kidney function and the risk of cardiovascular disease in patients with type 2 diabetes
    Wang, Yujie
    Katzmarzyk, Peter T.
    Horswell, Ronald
    Zhao, Wenhui
    Johnson, Jolene
    Hu, Gang
    [J]. KIDNEY INTERNATIONAL, 2014, 85 (05) : 1192 - 1199
  • [6] Development of Risk Prediction Models for Chronic Kidney Disease in Type 2 Diabetes Using Genetic and Clinical Variables
    Jiang, Guozhi
    Lau, Eric S.
    Wang, Ying
    Luk, Andrea O.
    Tam, Claudia H.
    Ho, Janice S.
    Lam, Vincent K.
    Lee, Heung Man
    Ng, Maggie C.
    Fan, Xiaodan
    So, Wing Yee
    Chan, Juliana C.
    Ma, Ronald C.
    [J]. DIABETES, 2012, 61 : A135 - A135
  • [7] Risk Factors for Kidney Disease in Type 1 Diabetes
    Perkins, Bruce A.
    Bebu, Ionut
    de Boer, Ian H.
    Molitch, Mark
    Tamborlane, William
    Lorenzi, Gayle
    Herman, William
    White, Neil H.
    Pop-Busui, Rodica
    Paterson, Andrew D.
    Orchard, Trevor
    Cowie, Catherine
    Lachin, John M.
    [J]. DIABETES CARE, 2019, 42 (05) : 883 - 890
  • [8] CANAGLIFLOZIN LOWERS THE RISK OF KIDNEY FAILURE BY A THIRD IN PEOPLE WITH TYPE 2 DIABETES AND KIDNEY DISEASE
    Idris, Iskandar
    [J]. DIABETES OBESITY & METABOLISM, 2019, 21 (07): : 1761 - 1761
  • [9] Relationship between genetic risk scores for type 2 diabetes and kidney function and adverse diabetes outcomes
    Pacal, L.
    Galuska, D.
    Chalasova, K.
    Hubacek, J. A.
    Lanska, V.
    Kankova, K.
    [J]. DIABETOLOGIA, 2022, 65 (SUPPL 1) : S383 - S384
  • [10] Cardiometabolic Risk Indicators for Kidney Disease in Mexican Patients with Type 2 Diabetes
    Velazquez-Lopez, Lubia
    Hernandez-Sanchez, Rubi
    Roy-Garcia, Ivonne
    Violeta Munoz-Torres, Abril
    Medina-Bravo, Patricia
    Escobedo-de la Pena, Jorge
    [J]. ARCHIVES OF MEDICAL RESEARCH, 2018, 49 (03) : 191 - 197